Literature DB >> 18219482

Degradation of myocardial perfusion SPECT images caused by contaminants in thallous (201Tl) chloride.

Steven G Staelens1, Tim C de Wit, Ignace A Lemahieu, Freek J Beekman.   

Abstract

PURPOSE: Thallous (201Tl) chloride is a single-photon emission computed tomography (SPECT) tracer mainly used for assessing perfusion and viability of myocardial tissue. 201Tl emits X-rays around 72 keV and gammas at 167 keV, and has a half-life of 73 h. Regulations allow an intrinsic contamination up to 3-5%, which is mainly caused by 200Tl (368 keV; 26 h) and by 202Tl (439 keV; 12.2 days). Contra-intuitive to the low-level percentages in which these contaminants are present, their impact may be significant because of much higher gamma camera sensitivity for these high-energy photon emissions. Therefore, we investigate the effects of the contaminants in terms of detected fractions of photons in projections and contrast degradation in reconstructed images.
METHODS: Acquisitions of a digital thorax phantom filled with thallous (201Tl) chloride were simulated with a validated Monte Carlo tool, thereby, modelling 1% of contamination by 200Tl and 202Tl each. In addition, measurements of a thorax phantom on a dual-headed gamma camera were performed. The product used was contaminated by 0.17% of 200Tl and 0.24% of 202Tl at activity reference time (ART). This ART is specified by the manufacturer, thereby, accounting for the difference in half-lives of 201Tl and its contaminants. These measurements were repeated at different dates associated with various contamination levels.
RESULTS: Simulations showed that, with 1% of 200Tl and 202Tl, the total contamination in the 72 keV window can rise up to one out of three detected photons. For the 167 keV window, the contamination is even more pronounced: more than four out of five detections in this photopeak window originate from contaminants. Measurements indicate that cold lesion contrast in myocardial perfusion SPECT imaging is at maximum close to ART. In addition to a higher noise level, relative contrast decreases 15% 2 days early to ART, which is explained by an increase in 200Tl contamination. After ART, contrast decreased by 16% when the 202Tl contamination increased to the maximal allowed limit.
CONCLUSIONS: Contra-intuitive to the low-level percentages in which they are typically present, penetration and downscatter of high-energy photons from 200Tl and 202Tl significantly contribute to thallous (201Tl) chloride images, thereby, reducing contrast and adding noise. These findings may prompt for improved production methods, for updated policies with regard to timing of usage, and they also render the usefulness of adding the high photopeak window (167 keV) questionable. A window-based correction method for this contamination is advisable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219482     DOI: 10.1007/s00259-008-0719-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  18 in total

1.  A rapid improved method for gamma-spectrometric determination of 202Tl impurities in [201Tl]-labelled radiopharmaceuticals.

Authors:  Mauro Bonardi; Flavia Groppi; Claudio Birattari
Journal:  Appl Radiat Isot       Date:  2002-11       Impact factor: 1.513

2.  GATE: a simulation toolkit for PET and SPECT.

Authors:  S Jan; G Santin; D Strul; S Staelens; K Assié; D Autret; S Avner; R Barbier; M Bardiès; P M Bloomfield; D Brasse; V Breton; P Bruyndonckx; I Buvat; A F Chatziioannou; Y Choi; Y H Chung; C Comtat; D Donnarieix; L Ferrer; S J Glick; C J Groiselle; D Guez; P F Honore; S Kerhoas-Cavata; A S Kirov; V Kohli; M Koole; M Krieguer; D J van der Laan; F Lamare; G Largeron; C Lartizien; D Lazaro; M C Maas; L Maigne; F Mayet; F Melot; C Merheb; E Pennacchio; J Perez; U Pietrzyk; F R Rannou; M Rey; D R Schaart; C R Schmidtlein; L Simon; T Y Song; J M Vieira; D Visvikis; R Van de Walle; E Wieërs; C Morel
Journal:  Phys Med Biol       Date:  2004-10-07       Impact factor: 3.609

3.  Long term retention and excretion of 201Tl in a patient after myocardial perfusion imaging.

Authors:  E Blanchardon; C Challeton-de Vathaire; P Boisson; D Célier; J-C Martin; S Cassot; G Herbelet; D Franck; J R Jourdain; A Biau
Journal:  Radiat Prot Dosimetry       Date:  2005-01-25       Impact factor: 0.972

4.  Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000.

Authors:  A D Kelion; C Anagnostopoulos; M Harbinson; S R Underwood; M Metcalfe
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

5.  Thallium-201: scintillation camera imaging considerations.

Authors:  M W Groch; G K Lewis
Journal:  J Nucl Med       Date:  1976-02       Impact factor: 10.057

6.  Fast hybrid SPECT simulation including efficient septal penetration modelling (SP-PSF).

Authors:  Steven Staelens; Tim de Wit; Freek Beekman
Journal:  Phys Med Biol       Date:  2007-05-08       Impact factor: 3.609

7.  [Estimation of radiation dose produced by impurities in nuclear medicine studies using Tl-201 chloride].

Authors:  C Bergamini; M Marengo; L Laudicina; G Mazzotti; M Dondi
Journal:  Radiol Med       Date:  1986-09       Impact factor: 3.469

8.  [Gamma-ray spectra of 201Tl-radiopharmaceuticals with a scintillation camera--crosstalk of contaminating nuclides of 200Tl and/or 202Tl onto 201Tl-photopeaks].

Authors:  K Saegusa; M Fukushi; Y Katoh; H Saitoh; T Irifune
Journal:  Radioisotopes       Date:  1990-06

9.  Simultaneous technetium-99m/thallium-201 SPECT imaging with model-based compensation for cross-contaminating effects.

Authors:  D J Kadrmas; E C Frey; B M Tsui
Journal:  Phys Med Biol       Date:  1999-07       Impact factor: 3.609

Review 10.  Assessment of myocardial viability.

Authors:  Mark I Travin; Steven R Bergmann
Journal:  Semin Nucl Med       Date:  2005-01       Impact factor: 4.446

View more
  1 in total

1.  Comments on contaminants in thallous (201Tl) chloride.

Authors:  Geert Ensing; Mark Konijnenberg; Jan Kees Beers; Enrico Seccamani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-12       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.